|
|
||||||||

1 Unité INSERM 74 and Institut de Virologie de la Faculté de Médecine, Université Louis Pasteur, 3 rue Koeberlé, 67000 Strasbourg
and2 Transgène, 11 rue de Molsheim, 67082 Strasbourg, France
Simian immunodeficiency virus (SIV) and human immunodeficiency virus type 2 (HIV-2) encode the accessory viral protein X (Vpx) known to be incorporated into virions in amounts comparable to those of the Gag proteins. The localization of Vpx within SIVmac-infected HUT-78 cells and SIVmac virions was studied by immunoelectron microscopy. Vpx appeared to be associated with extracellular virions as well as budding viral particles at the surface of infected cells. Immunolabelling of purified viral cores suggested that Vpx was a component of the amorphous material surrounding the core structure. Furthermore, a detergent insoluble fraction containing SIV core proteins was devoid of Vpx. To investigate the protein requirement for packaging of Vpx, BHK-21 cells were co-infected with vaccinia virus recombinants encoding Vpx and other SIV proteins able to assemble into virus-like particles. Analysis by immunoprecipitation of the extracellular particulate material as well as immunoelectron microscopy demonstrated that co-expression of Vpx with the Pr56gag polyprotein was sufficient for the formation of pseudo-virions containing Vpx. Virus-like particles that appeared upon expression of p16gag did not contain Vpx. The results suggest that Vpx is packaged into viral particles through its binding to the Gag polyprotein. The precise positioning of Vpx within the space separating the viral envelope from the core structure is postulated to result from the reorganization of viral proteins that occurs upon Gag polyprotein cleavage and budding.
Present address: Laboratory of Molecular Virology and Carcinogenesis, ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, U.S.A.
Received 21 February 1994;
accepted 21 June 1994.
This article has been cited by other articles:
![]() |
A. Öhagen and D. Gabuzda Role of Vif in Stability of the Human Immunodeficiency Virus Type 1 Core J. Virol., December 1, 2000; 74(23): 11055 - 11066. [Abstract] [Full Text] |
||||
![]() |
B. Müller, U. Tessmer, U. Schubert, and H.-G. Kräusslich Human Immunodeficiency Virus Type 1 Vpr Protein Is Incorporated into the Virion in Significantly Smaller Amounts than Gag and Is Phosphorylated in Infected Cells J. Virol., October 15, 2000; 74(20): 9727 - 9731. [Abstract] [Full Text] |
||||
![]() |
M. A. Accola, A. Öhagen, and H. G. Göttlinger Isolation of Human Immunodeficiency Virus Type 1 Cores: Retention of Vpr in the Absence of p6gag J. Virol., July 1, 2000; 74(13): 6198 - 6202. [Abstract] [Full Text] |
||||
![]() |
R. Welker, H. Hohenberg, U. Tessmer, C. Huckhagel, and H.-G. Kräusslich Biochemical and Structural Analysis of Isolated Mature Cores of Human Immunodeficiency Virus Type 1 J. Virol., February 1, 2000; 74(3): 1168 - 1177. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |